OmniAb (OABI) Net Margin (2022 - 2026)

OmniAb (OABI) posted quarterly Net Margin of 53.42% for Q1 2026, up 38471.0% year-over-year from N/an in Q1 2025, and up 68.44% quarter-over-quarter from 169.28% in Q4 2025.

OmniAb (OABI) Net Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has reported Net Margin for 5 consecutive years, with 53.42% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin rose 38471.0% year-over-year to 53.42%; the TTM figure through Mar 2026 stood at 187.59% (up 4152.0% YoY), while the FY2025 annual figure was 347.04%, down 11199.0% from the prior year.
  • Net Margin grew to 53.42% in Q1 2026 per OABI's latest filing, from 169.28% in the prior quarter.
  • Across five years, Net Margin topped out at 19.3% in Q4 2022 and bottomed at 738.05% in Q3 2025.
  • Historically, Net Margin has averaged 228.81% across 5 years, with a median of 179.03% in 2024.
  • Annual changes were most pronounced in 2024 — Net Margin slumped 46279 bps — and 2026, when it soared 38471 bps.
  • OmniAb's Net Margin stood at 19.3% in 2022, then tumbled by 1610 bps to 291.44% in 2023, then surged by 58 bps to 120.96% in 2024, then slumped by 40 bps to 169.28% in 2025, then jumped by 68 bps to 53.42% in 2026.
  • Business Quant data shows OABI's Net Margin at 53.42% in Q1 2026, 169.28% in Q4 2025, and 738.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 OmniAb 491.42 Mn 439.42 Mn 12.81 Mn -43.67%

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.67%
Mar 31, 2026 -53.42%
Dec 31, 2025 -169.28%
Sep 30, 2025 -738.05%
Jun 30, 2025 -407.36%
Mar 31, 2025 -438.13%
Dec 31, 2024 -120.96%
Sep 30, 2024 -392.45%
Jun 30, 2024 -179.03%
Mar 31, 2024 -498.84%
Dec 31, 2023 -291.44%
Sep 30, 2023 -287.35%
Jun 30, 2023 -212.04%
Mar 31, 2023 -36.05%
Dec 31, 2022 19.30%
Sep 30, 2022 -28.55%
Jun 30, 2022 -18.06%
Mar 31, 2022 -38.13%